SEO URLwww.firestrike.ai/deals/ventyx-biosciences-lilly-acquisition-2026-12
acquisitionAnnounced · Feb 7, 2026PharmaceuticalsSource · RumorsArticle · Expectations
Lilly acquires Ventyx Biosciences
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$1B
Target
Ventyx Biosciences
NASDAQ: VTYX · San Diego, California
Acquirer
Lilly
Full Acquisition
Status
Pending
Lilly agreed to acquire Ventyx Biosciences. Reported deal value: $1B. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: San Diego, California, United States.
This page summarizes publicly available information about the transaction as of 2026-02-07. Figures and status may change as filings and press coverage update.
Ventyx Biosciences Acquisition : A $1.2 Billion Strategic Move by Eli Lilly 07.02.2026
Deal timeline
Announced
Feb 7, 2026 · ad-hoc-news.de
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $1B. Figures and status may change as sources update.
Sources: ad-hoc-news.de · Primary article · FireStrike proprietary index